Reuters Health News Summary

Following is a summary of current health news briefs. Sanofi and Regeneron cut list price of cholesterol drug by 60 percent

Sanofi SA and Regeneron Pharmaceuticals Inc said on Monday that they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 percent, as the drugmakers follow a similar move by rival Amgen Inc in hopes of increasing use of the drug. The new list price for Praluent will be $5,850 a year, matching the price Amgen set when it lowered the list of its competing drug, Repatha, in October. Seven mumps cases confirmed at Houston ICE detention facility

Seven adult detainees at a U.S. Immigration and Customs Enforcement detention facility in Houston have been diagnosed with mumps, but the contagious disease is contained, the city's health department said on Saturday. "Since these individuals were isolated inside the facility during the period they were infectious, we do not anticipate these cases posing a threat to the community," Dr. David Persse, Houston's local health authority and emergency medical services medical director, said in a statement. ICE's Houston Contract Detention Facility houses approximately 950-1,000 adults. Dementia patient over-medicated and bruised when he died, widow tells Australian aged care inquiry

An elderly man suffering Parkinson's Disease and dementia was given 10 times his medication and had unexplained bruising when he died at an Australian aged care facility, his widow told an inquiry into the A$20 billion ($14 billion) aged care sector. A Royal Commission inquiry into Australia's aged care industry began hearings on Monday, after a slew of reports of dementia patients being bound in restraints, assaults on patients, overdosing, predatory pricing and poor care.